United States

Smith & Nephew PLC (SNN.N)

SNN.N on New York Stock Exchange

24 May 2017
Change (% chg)

$0.11 (+0.32%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Latest Key Developments (Source: Significant Developments)

Smith & Nephew says CFO leaves co as announced in July
Thursday, 12 Jan 2017 07:14am EST 

Smith & Nephew Plc : Directorate change .Julie Brown, Chief Financial Officer, left company.  Full Article

Smith & Nephew starts share buyback after gynaecology divestment completes
Monday, 8 Aug 2016 02:00am EDT 

Smith & Nephew Plc : Smith & nephew completes gynaecology sale and commences $300 million share buy-back programme . Completion of sale and commencement of buy-back . Smith & nephew completes gynaecology sale and commences $300 million share buy-back programme . Completed divestiture of its gynaecology business to medtronic plc (nyse:mdt) for $350 million. .Maximum pecuniary amount allocated to buy-back programme is $300 million and maximum number of shares that will be purchased is estimated to be 18.3 million.  Full Article

Smith & Nephew says CFO Julie Brown to leave for Burberry
Monday, 11 Jul 2016 08:56am EDT 

Smith & Nephew Plc : Julie Brown, chief financial officer, will be leaving company in Jan. 2017 to join Burberry as chief operating and financial officer .Search for a successor to Julie is underway, and a further announcement will be made in due course.  Full Article

Burberry names Smith & Nephew's Julie Brown as new CFO
Monday, 11 Jul 2016 08:50am EDT 

Burberry Group Plc : Julie Brown appointed as new chief operating & financial officer . Reporting to chief executive officer, Julie Brown will join business and board in early 2017 . Julie is currently chief financial officer at global medical technology business Smith And Nephew Plc .Says Julie qualified with KPMG before working at ICI and AstraZeneca Plc.  Full Article

Smith & Nephew sells gynaecology unit to Medtronic
Wednesday, 18 May 2016 08:00am EDT 

Smith & Nephew Plc : Divestment and share buy-back . Signed a definitive agreement to divest its gynaecology business to Medtronic Plc (NYSE:MDT) for $350 million. . Gynaecology delivered revenue of $56 million in 2015, representing a little over 1% of group revenue. . Transaction is expected to be broadly neutral to adjusted earnings ('EPSA') in 2017, after share buy-back, . Share buy back is expected to commence shortly after completion in July 2016 . Proceeds will be returned to shareholders through a $300 million share buy-back programme. . Gross proceeds are before tax and costs. . Is expected that majority of gynaecology employees will join Medtronic . Davis Polk & Wardwell Llp served as counsel to Smith & Nephew and Ondra Partners acted as financial advisor. .Divestment and share buy-back.  Full Article

Smith & Nephew Plc acquires first-line cartilage repair product
Tuesday, 12 Jan 2016 08:00am EST 

Smith & Nephew Plc:Acquires first-line cartilage repair product.Terms of the transaction were not disclosed.  Full Article

Smith & Nephew plc completes acquisition of Blue Belt Holdings Inc
Tuesday, 5 Jan 2016 02:00am EST 

Smith & Nephew plc:Says it has completed the acquisition of Blue Belt Holdings, Inc.  Full Article

Smith & Nephew plc acquires Blue Belt Technologies
Thursday, 29 Oct 2015 03:00am EDT 

Smith & Nephew plc:Says that it has agreed to acquire Blue Belt Holdings, Inc. for $275 million.  Full Article

Smith & Nephew plc reaffirms FY 2015 guidance; declares interim dividend
Thursday, 30 Jul 2015 02:02am EDT 

Smith & Nephew plc:Says that outlook for FY 2015 remains unchanged.Says that it continue to expect to deliver higher underlying revenue growth in FY 2015 than in FY 2014.Says interim dividend for the H1 2015 is 11.8¢ per share (23.6¢ per ADS), compared with 11.0¢ last year.The interim dividend will be paid on Oct. 27 to shareholders on the register at the close of business on Oct. 9.  Full Article

Biotec Pharmacon ends discussion about Woulgan distribution agreement with Smith & Nephew
Tuesday, 7 Jul 2015 04:20am EDT 

Biotec Pharmacon ASA:Biotec Pharmacon ASA and Smith & Nephew have mutually decided to end the discussion about a Woulgan distribution agreement.  Full Article

More From Around the Web

RPT-UPDATE 1-Emerging markets growth puts Smith & Nephew on track for year

LONDON, May 5 Shares in Smith & Nephew rose to a nine-month high on Friday after the artificial hip and knee maker said a strong first quarter, led by growth in emerging markets, put it on track to meet it targets for the year.